Published in Health and Medicine Week, October 27th, 2003
Ventures West led the round and was joined by other new investors, H.I.G. Ventures and Working Opportunity Fund, managed by GrowthWorks Capital. The syndicate also included existing investors Business Development Bank of Canada and Milestone Medica Corp.
"Attracting this strong syndicate of investors in this oversubscribed round is testament to their confidence in our products and capabilities," said Scott Cormack, president and chief executive officer of OncoGenex. "These funds provide cash to continue the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.